Dolphin
Senior Member (Voting Rights)
Free full text:
https://www.clinexprheumatol.org/article.asp?a=15345
https://www.clinexprheumatol.org/article.asp?a=15345
Review
One year in review 2020: fibromyalgia
L. Bazzichi1, C. Giacomelli1, A. Consensi1, V. Giorgi2, A. Batticciotto3, M. Di Franco4, P. Sarzi-Puttini2
ABSTRACT
Fibromyalgia (FM) is a frequently encountered syndrome that is charac-terised by chronic widespread pain, fatigue, sleep disturbances, and many other symptoms that impair the quality of life.
Its aetiopathogenesis is still un-clear but, although there is no specific therapy, a number of pharmacological and non-pharmacological therapies are available.
The aim of this review is to describe the most recent findings concerning the diagnosis, aetiopatho-genesis and treatment of FM published between January 2019 and January 2020.
They include the new concept of nociplastic pain, some neuroendocrine and metabolic alterations found in FM patients, and investigations concerning not only novel applications of old drugs, but also, and in particular, complemen-tary therapies, such as the hyperbaric oxygen chamber, ozone therapy and mindfulness-based interventions.